 Aurinia Pharmaceuticals Inc NASDAQ: AUPH has presented additional efficacy data from the AURA-LV and AURORA 1 trials of Lupkynis voclosporin in lupus nephritis LN. Aurinia shared the data at the National Kidney Foundation 2021 Spring Clinical Meeting. 